Recent Publications

Nita Amornsiripanitch, MD, 2022 Gayle Brinkenhoff IGNITE Awardee

• “Reducing Barriers to Care in Screening Mammography Among Underserved Populations Through a Quality Improvement Approach”, Journal of the American College of Radiology, September 2022.

Deborah Bartz, MD, MPH, Director of Education

• “Restrictive State Abortion Bans — A Reproductive Injustice”, New England Journal of Medicine, March 2022.
• “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, August 2022.
• “Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access”, Obstetrics and Gynecology, August 2022.

Behnood Bikdeli, MD, MS, Tynan Research Fellow, 2021 Specialized Cardiac & Vascular IGNITE Awardee

• “Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study”, Thrombosis Research, June 2022.
• “Direct Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials”, Journal of the American College of Cardiology, October 2022.

Rohini Dutta, MBBS, 2022 Global Women’s Health Fellow

• “Academic Output in Global Surgery after the Lancet Commission on Global Surgery: A Scoping Review”, World Journal of Surgery, July 2022.
• “Breast Conservative Surgery for Breast Cancer: Indian Surgeon’s Preferences and Factors Influencing Them”, Indian Journal of Surgical Oncology, August 2022.
• “Open Letter to G7 and G20 leaders: resolve global crises to secure our future”, Nature Medicine, August 2022.

Leilah Grant, PhD, Tynan Research Fellow

• “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
• “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.

Alisa Goldberg, MD, MPH, Director of the Complex Family Planning Fellowship

• “Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location”, Obstetrics and Gynecology, May 2022.

Tianyi Huang, ScD, 2018 WHISPR Awardee

• “Plasma Metabolomic Signature of Early Abuse in Middle-Aged Women”, Psychosomatic Medicine, June 2022.

Hadine Joffe, MD, MSc, Executive Director

• “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
• “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
• “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
• “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.
• “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.

Vesela Kovacheva,MD, PhD, 2021 IGNITE Awardee

• “A survey of pregnant patients’ perspectives on the implementation of artificial intelligence in clinical care”, Journal of the American Medical Informatics Association, October 2022.

Cindy Liu, PhD, Director of Psychosocial Stress, Diversity, and Health

• “Maternal Milk Provision in the Neonatal Intensive Care Unit and Mother-Infant Emotional Connection for Preterm Infants”, Children, February 2022.
• “COVID-19 Pandemic Experiences and Maternal Stress in Neonatal Intensive Care Units”, Children, February 2022.
• “Maternal Self-Efficacy Buffers the Effects of COVID-19–Related Experiences on Postpartum Parenting Stress“, Journal of Obstetric, Gynecologic, and Neonatal Nursing, March 2022.
• “Unmet Prenatal Expectations During the COVID-19 Pandemic”, The American Journal of Maternal/Child Nursing, March 2022.
• “Subjective social status, COVID-19 health worries, and mental health symptoms in perinatal women”, Social Science and Medicine – Population Health, June 2022.

Morteza Mahmoudi, PhD, 2019 Traditional IGNITE Awardee

• “Sex-Specific Silica Nanoparticle Protein Corona Compositions Exposed to Male and Female BALB/c Mice Plasmas”, ACS Bio & Med Chem Au, November 2022.

JoAnn Manson, MD, DrPH, MACP, Scientific Advisor

• “The impact of the COVID-19 pandemic on older women in the Women’s Health Initiative“, J Gerontol A Biol Sci Med Sci, March 2022.
• “Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity”, The American Journal of Clinical Nutrition, April 2022.
• “Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial”, American Journal of Clinical Nutrition, June 2022.
• “Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial”, American Journal of Clinical Nutrition, June 2022.
• “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, July 2022.
• “Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials”, British Journal of Cancer, September 2022.
• “Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo”, JAMA Cardiology, November 2022.

Lidia Minguez-Alarcon, PhD, MPH, 2022 WHISPR Awardee

• “Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva”, Menopause, October 2022.

Margo Nathan, MD, 2020 WHISPR Awardee

• “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
• “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
• “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.

Michelle O’Donoghue, MD, MPH

• “Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease”, New England Journal of Medicine, November 2022.

Emily Oken, MD, MPH, ROSA Project Co-Leader

• “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.
• “Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva”, Menopause, October 2022.

Isioma Okolo, MBChB, MRCOG, DTMH, 2020 Global Women’s Health Fellow

• “Training in Ultrasound to Determine Gestational Age in Low- and Middle- Income Countries: A Systematic Review”, Frontiers in Global Women’s Health, March 2022.
• “Shifting global surgery’s center of gravity”, Surgery, June 2022.

Chiamaka Onwuzurike, MD, MPH, 2021 Global Women’s Health Fellow

• “Restrictive State Abortion Bans — A Reproductive Injustice”, New England Journal of Medicine, March 2022.
• “Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access”, Obstetrics and Gynecology, August 2022.
• “Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example”, Contraception, November 2022.

Maria Pabon, MD, First.In.Women Fellow

• “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER”, Circulation, November 2022.

Lydia Pace, MD, MPH, Director of Women’s Health Policy and Advocacy and the Global Women’s Health Fellowship

• “Association of Medicaid Reimbursement for Immediate Postpartum Long-acting Reversible Contraception With Infant Birth Outcomes”, JAMA Pediatrics, March 2022.
• “BRCA1/2 testing among young women with breast cancer in Massachusetts, 2010-2013: An observational study using state cancer registry and All-Payer claims data”, Cancer Medicine, March 2022.
• “False-Positive Results of Mammography Screening in the Era of Digital Breast Tomosynthesis”, JAMA Network Open, March 2022.
• “Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women”, JAMA Network Open, April 2022.
• “Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults”, New England Journal of Medicine, August 2022.

Shadab Rahman, PhD, MPH

• “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
• “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.

Janet Rich-Edwards, ScD, MPH, Director of Lifecourse Epidemiology

• “Associations between predicted vitamin D status, vitamin D intake, and risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) severity”, The American Journal of Clinical Nutrition, April 2022.
• “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
• “Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife”, Menopause, September 2022.

Primavera Spagnolo, MD, PhD, Scientific Director, First.In.Women

• “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.

Wendy Wang, MD, First.In.Women Fellow

• “Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER”, Circulation, November 2022.

Aleta Wiley, MPH, MSc, Director of Research Program Management

• “A double-blind, randomized, placebo-controlled trial of suvorexant for the treatment of vasomotor symptom-associated insomnia disorder in midlife women”, Sleep, March 2022.
• “Enrollment of female participants in United States drug and device phase 1–3 clinical trials between 2016 and 2019”, Contemporary Clinical Trials, April 2022.
• “Sleep Fragmentation and Estradiol Suppression Decrease Fat Oxidation in Premenopausal Women”, Journal of Clinical Endocrinology and Metabolism, July 2022.
• “Disruption of Sleep Continuity During the Perimenopause: Associations with Female Reproductive Hormone Profiles”, Journal of Clinical Endocrinology and Metabolism, September 2022.